Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $17,800 | 18 | 91.0% |
| Food and Beverage | $1,129 | 61 | 5.8% |
| Travel and Lodging | $629.82 | 11 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $18,595 | 40 | $0 (2022) |
| AbbVie Inc. | $215.96 | 11 | $0 (2023) |
| Astellas Pharma US Inc | $170.72 | 8 | $0 (2024) |
| PFIZER INC. | $127.27 | 7 | $0 (2024) |
| Novo Nordisk Inc | $117.00 | 7 | $0 (2023) |
| Amgen Inc. | $66.60 | 3 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $60.37 | 4 | $0 (2023) |
| Organon Llc | $49.01 | 3 | $0 (2024) |
| Quidel Corporation | $45.25 | 1 | $0 (2023) |
| Lucid Diagnostics Inc. | $33.65 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $107.47 | 5 | Astellas Pharma US Inc ($57.52) |
| 2023 | $326.12 | 16 | Astellas Pharma US Inc ($88.20) |
| 2022 | $362.01 | 18 | ABBVIE INC. ($96.19) |
| 2021 | $71.06 | 4 | AbbVie Inc. ($37.41) |
| 2020 | $29.44 | 2 | Novo Nordisk Inc ($29.44) |
| 2019 | $5,153 | 18 | Merck Sharp & Dohme Corporation ($5,068) |
| 2018 | $5,118 | 10 | Merck Sharp & Dohme Corporation ($5,118) |
| 2017 | $8,392 | 17 | Merck Sharp & Dohme Corporation ($8,392) |
All Payment Transactions
90 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/28/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: PAIN | ||||||
| 08/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/30/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $34.43 | General |
| Category: Biological | ||||||
| 04/25/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: ETONOGESTREL | ||||||
| 03/05/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Biological | ||||||
| 11/20/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Biological | ||||||
| 11/07/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/24/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.47 | General |
| Category: Cardiovascular | ||||||
| 10/20/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Obesity | ||||||
| 10/19/2023 | Quidel Corporation | — | Food and Beverage | In-kind items and services | $45.25 | General |
| 09/26/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $30.97 | General |
| Category: Biological | ||||||
| 08/07/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/17/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Biological | ||||||
| 06/26/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Biological | ||||||
| 04/17/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/07/2023 | MAYNE PHARMA COMMERCIAL LLC | NEXTSTELLIS (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: CONTRACEPTIVE | ||||||
| 02/28/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: NEUROSCIENCE | ||||||
| 01/10/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.87 | General |
| Category: Cardiovascular | ||||||
| 01/05/2023 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $13.99 | General |
| 11/08/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: Urology | ||||||
| 10/11/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/25/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.87 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 655 | 783 | $105,587 | $54,326 |
| 2022 | 12 | 635 | 787 | $90,089 | $44,636 |
| 2021 | 16 | 716 | 961 | $94,923 | $50,145 |
| 2020 | 12 | 701 | 943 | $98,068 | $47,108 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 124 | 124 | $17,360 | $14,742 | 84.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 89 | 148 | $35,006 | $11,247 | 32.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 28 | 28 | $10,080 | $7,892 | 78.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 102 | 142 | $23,826 | $6,987 | 29.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 48 | 50 | $4,632 | $3,757 | 81.1% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 23 | 23 | $3,335 | $2,955 | 88.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $1,980 | $1,677 | 84.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 50 | 52 | $2,692 | $1,473 | 54.7% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 26 | 26 | $2,990 | $889.72 | 29.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 79 | 104 | $1,040 | $873.60 | 84.0% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 23 | 23 | $1,012 | $868.48 | 85.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 30 | 30 | $1,320 | $849.60 | 64.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 11 | 11 | $115.50 | $66.66 | 57.7% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 11 | 11 | $198.00 | $48.29 | 24.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 118 | 118 | $16,520 | $14,277 | 86.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 101 | 168 | $34,912 | $11,176 | 32.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 84 | 120 | $17,836 | $6,269 | 35.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 11 | 11 | $3,920 | $3,051 | 77.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 37 | 37 | $3,295 | $2,579 | 78.3% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 15 | 15 | $2,235 | $1,974 | 88.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 44 | 44 | $2,131 | $1,182 | 55.5% |
| 0054A | Adm sarscv2 30mcg trs-sucr b | Office | 2022 | 28 | 28 | $1,680 | $1,005 | 59.8% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 27 | 27 | $1,620 | $960.12 | 59.3% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 26 | 26 | $2,990 | $870.02 | 29.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 30 | 30 | $1,320 | $809.84 | 61.4% |
About Dr. Ginger Allen, MD
Dr. Ginger Allen, MD is a Family Medicine healthcare provider based in Meridian, Idaho. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568490340.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ginger Allen, MD has received a total of $19,559 in payments from pharmaceutical and medical device companies, with $107.47 received in 2024. These payments were reported across 90 transactions from 14 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($17,800).
As a Medicare-enrolled provider, Allen has provided services to 2,707 Medicare beneficiaries, totaling 3,474 services with total Medicare billing of $196,214. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Adult Medicine, Family Medicine
- Location Meridian, ID
- Active Since 06/29/2006
- Last Updated 07/17/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1568490340
Products in Payments
- NEXPLANON (Drug) $18,611
- ELIQUIS (Drug) $160.38
- Veozah (Drug) $145.72
- QULIPTA (Drug) $106.19
- UBRELVY (Drug) $88.94
- Ozempic (Drug) $80.89
- EVENITY (Biological) $66.60
- NURTEC ODT (Drug) $42.98
- Rybelsus (Drug) $21.23
- LEQVIO (Drug) $19.56
- NEXTSTELLIS (Drug) $18.02
- BELSOMRA (Drug) $16.52
- Wegovy (Drug) $14.88
- BYDUREON (Drug) $12.97
- VESICARE (Drug) $12.85
- Myrbetriq (Drug) $12.15
- CHANTIX (Drug) $11.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Meridian
David Butuk, Md, MD
Family Medicine — Payments: $303,128
Mark Turner, Md, MD
Family Medicine — Payments: $221,327
Andrea Goodwin, M.d, M.D
Family Medicine — Payments: $194,380
Timothy Mchugh, Md, MD
Family Medicine — Payments: $182,889
Dr. Mark Macumber, Md, MD
Family Medicine — Payments: $37,593
Dr. Douglas Phillips, M.d, M.D
Family Medicine — Payments: $13,843